Diagenode Announces Acquisition of Service Provider NXT-Dx to Complement Epigenetics Assay Services

Monday, August 20, 2018 New acquisition rounds out Diagenode’s epigenomics profiling services platform DENVILLE, N.J. AND LIEGE, BELGIUM (PRWEB) AUGUST 16, 2018 Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics services including a number of targeted DNA methylation assays using... Read more

RedShiftBio Strengthens Focus on Applications with New Hire

AuthorBy B0ydR0nRSBPosted onAugust 17, 2018 Following the successful introduction of the AQS3TMpro, a protein characterization platform that allows users to ‘See Change in the secondary structure of proteins, the company is directing its focus to application development. Valerie Ivancic has joined the team as an Applications Scientist. She brings experience in the biophysical characterization of amyloid... Read more

BD Elects Jeffrey Henderson to Board of Directors

FRANKLIN LAKES, N.J., Aug. 16, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Jeffrey W. Henderson has been elected to the company’s board of directors. Henderson, 53, is the non-executive chairman of the board of Qualcomm, Inc. and serves on the board of directors at FibroGen, Inc. and Halozyme Therapeutics, Inc. as well as serving... Read more

Corporate Responsibility – Sartorius Earns Silver in EcoVadis CSR Rating

Göttingen, August 16, 2018 – Sartorius, a leading international partner of the biopharmaceutical industry and the research sector, has been awarded for its responsible activities in the areas of environment, labor practices, ethics and sustainable procurement. The company’s engagement in CSR ranges from supporting the United Nations Global Compact to reducing consumption of water in... Read more

Tecan accelerates broad genomics strategy with the acquisition of NuGEN Technologies

August 16, 2018 Acquisition of US-based NuGEN expands Tecan’s dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan’s Life Sciences Business, leveraging Tecan’s... Read more

Merck KGaA, Darmstadt, Germany, Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck KGaA, Darmstadt, Germany, today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. 15 AUG 2018 | DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic... Read more

New compact process photometer – economical online monitoring of industrial wastewater and more

8/13/2018 Metrohm Process Analytics presents the new 2029 Process Photometer, an integrated solution for 24/7 online analysis of critical chemical parameters in industrial processes and wastewater streams. This single-method system performs photometric absorption measurements in the visible light range and is available in several application-specific configurations for monitoring up to 2 process streams. Sensitive, accurate... Read more

Sphere Fluidics Appoints Dr Tris Vaughan (Vice President R&D Antibody Discovery and Protein Engineering for MedImmune) to their Scientific Advisory Board.

August 13, 2018 02:09 AM Pacific Daylight Time CAMBRIDGE, England–(BUSINESS WIRE)–Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development... Read more

Gyros Protein Technologies introduces Gyrolab CHO-HCP E3G Kit for impurity testing of biotherapeutics

Incorporates Cygnus Technologies’ gold standard reagents Ready-to-use immunoassay kit designed to increase productivity   Uppsala, Sweden, 13 August 2018 Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls) – bioprocess workflow of... Read more